News + Filings Transactions Holdings
All
13F
13D/G
Other
|
|
ESHELMAN FREDRIC N
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 02/13/2023 |
SC 13D/A
| Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend] |
| 04/05/2022 |
SC 13D/A
| ESHELMAN FREDRIC N reports a 34% stake in Aravive, Inc. |
| 02/18/2021 |
SC 13D/A
| ESHELMAN FREDRIC N reports a 19.8% stake in Aravive, Inc. |
| 08/28/2020 |
SC 13D/A
| ESHELMAN FREDRIC N reports a 6.8% stake in Eyenovia, Inc. |
| 08/14/2020 |
SC 13D/A
| ESHELMAN FREDRIC N reports a 8.2% stake in Eyenovia, Inc. |
| 08/20/2019 |
SC 13D/A
| ESHELMAN FREDRIC N reports a 9.7% stake in Eyenovia, Inc. |
| 04/29/2014 |
SC 13D/A
| ESHELMAN FREDRIC N reports a 27.2% stake in FURIEX PHARMACEUTICALS, INC. |
| 06/29/2012 |
SC 13D/A
| ESHELMAN FREDRIC N reports a 28.6% stake in FURIEX PHARMACEUTICALS, INC. |
| 06/04/2012 |
SC 13D/A
| ESHELMAN FREDRIC N reports a 27.1% stake in FURIEX PHARMACEUTICALS, INC. |
| 05/31/2012 |
SC 13D/A
| ESHELMAN FREDRIC N reports a 25.9% stake in FURIEX PHARMACEUTICALS, INC. |
| 05/25/2012 |
SC 13D/A
| ESHELMAN FREDRIC N reports a 24.2% stake in FURIEX PHARMACEUTICALS, INC. |
| 03/13/2012 |
SC 13D/A
| ESHELMAN FREDRIC N reports a 22.6% stake in FURIEX PHARMACEUTICALS, INC. |
| 02/17/2012 |
SC 13D/A
| ESHELMAN FREDRIC N reports a 21.1% stake in FURIEX PHARMACEUTICALS, INC. |
| 12/15/2011 |
SC 13D/A
| Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend] |
| 12/05/2011 |
SC 13D/A
| Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend] |
| 11/15/2011 |
SC 13D/A
| Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend] |
| 11/09/2011 |
SC 13D/A
| Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend] |
| 05/26/2011 |
SC 13D/A
| Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend] |
| 05/23/2011 |
SC 13D/A
| ESHELMAN FREDRIC N reports a 12% stake in FURIEX PHARMACEUTICALS, INC. |
|
|